Contrasting predictors of severe primary graft dysfunction following transplant for chronic and acute respiratory failure

Chitaru Kurihara, Taisuke Kaiho, Benjamin Thomae, Emily Cerier, Kalvin Lung, Diego Avella Patino, Takahide Toyoda, Yuanqing Yan, G. R. Scott Budinger, Ankit Bharat*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Lung transplantation represents a pivotal intervention for individuals grappling with end-stage lung diseases, and the role of lung transplantation in acute respiratory distress syndrome (ARDS) patients has garnered increased attention especially after the coronavirus disease 2019 (COVID-19) pandemic. Multiple studies have demonstrated a high incidence of primary graft dysfunction (PGD) in patients with ARDS compared to contemporaneous controls undergoing transplantation for chronic end-stage lung diseases although underlying mechanisms or risk factors remain unknown. This retrospective study investigates the contrasting risk factors for PGD grade 3 in patients with ARDS and chronic respiratory failure undergoing lung transplantation. Methods: The study included 293 patients who underwent lung transplantation from January 2018 through June 2023. We performed a multivariate logistic regression analysis using variables from the univariate logistic regression analyses to predict PGD grade 3. Results: Our findings reveal distinct predictors for PGD grade 3 in the two cohorts. ARDS patients had higher incidence of PGD grade 3 than non-ARDS patients (30.2% vs. 9.6%, P<0.001). Multivariate logistic regression analysis showed ischemic time [odds ratio (OR) =0.60; 95% confidence interval (CI): 0.40–0.90; P=0.01] as predictor of PGD grade 3 for non-ARDS patients, and age (OR =0.72; 95% CI: 0.52–0.99; P=0.048), pre-operative albumin (OR <0.01; 95% CI: <0.01–0.74; P=0.042) for ARDS patients. Interestingly, there was no notable difference in post-transplant survival between the two groups. Conclusions: This study highlights differing risk profiles for severe PGD in ARDS and non-ARDS lung transplant recipients, underscoring the need for tailored approaches in managing these patients. It paves the way for further research to refine strategies aimed at reducing PGD incidence and enhancing transplant outcomes in these distinct populations.

Original languageEnglish (US)
Pages (from-to)5050-5062
Number of pages13
JournalJournal of Thoracic Disease
Volume16
Issue number8
DOIs
StatePublished - Aug 2024

Funding

The authors would like to thank Ms. Elena Susan for her administrative assistance in the submission of this manuscript. This work was supported by the National Institutes of Health (Nos. HL145478, HL147290, and HL147575 to A.B.).

Keywords

  • Acute respiratory distress syndrome (ARDS)
  • lung transplant
  • primary graft dysfunction (PGD)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Contrasting predictors of severe primary graft dysfunction following transplant for chronic and acute respiratory failure'. Together they form a unique fingerprint.

Cite this